Figure 2.
Activation of MALT1 is caused by constitutive BCR signaling in MCL. (A) Western blot analysis of CD79A, CARD11, CYLD, RelB, and BCL10 following shRNA-mediated knockdown of CD79A and CARD11, respectively. Cleavage of CYLD, RelB, and BCL10 was significantly downregulated following CD79A or CARD11 knockdown, respectively, in MALT1-activated cell lines (Jeko-1 and Rec-1), whereas none of these cleaved forms was detectable in MALT1-inactive cell lines (Maver-1 and Z-138) and the expression levels of the corresponding full-length forms were not affected. (B) shRNA-mediated knockdown of CD79A and CARD11 was toxic to the MALT1-activated cell lines Jeko-1 and Rec-1. In contrast, the MALT1-inactive cell lines Maver-1 and Z-138 were unaffected by CD79A and CARD11 knockdown. A previously described, nontoxic shRNA against MSMO1 did not induce toxicity in any cell line. Data are shown as means ± standard deviations (SDs) of at least 3 independent experiments. (C) Cell viability of MCL cell lines after incubation with the BTK inhibitor ibrutinib. Representative results from at least 3 independent replicates are shown. Error bars indicate SDs.

Activation of MALT1 is caused by constitutive BCR signaling in MCL. (A) Western blot analysis of CD79A, CARD11, CYLD, RelB, and BCL10 following shRNA-mediated knockdown of CD79A and CARD11, respectively. Cleavage of CYLD, RelB, and BCL10 was significantly downregulated following CD79A or CARD11 knockdown, respectively, in MALT1-activated cell lines (Jeko-1 and Rec-1), whereas none of these cleaved forms was detectable in MALT1-inactive cell lines (Maver-1 and Z-138) and the expression levels of the corresponding full-length forms were not affected. (B) shRNA-mediated knockdown of CD79A and CARD11 was toxic to the MALT1-activated cell lines Jeko-1 and Rec-1. In contrast, the MALT1-inactive cell lines Maver-1 and Z-138 were unaffected by CD79A and CARD11 knockdown. A previously described, nontoxic shRNA against MSMO1 did not induce toxicity in any cell line. Data are shown as means ± standard deviations (SDs) of at least 3 independent experiments. (C) Cell viability of MCL cell lines after incubation with the BTK inhibitor ibrutinib. Representative results from at least 3 independent replicates are shown. Error bars indicate SDs.

Close Modal

or Create an Account

Close Modal
Close Modal